CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines
LOS ANGELES--(BUSINESS WIRE)---- $PHR--PHR Investors Have Opportunity to Join Phreesia, Inc. Fraud Investigation with the Schall Law Firm.
LOS ANGELES, April 3, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Lakeland Industries, Inc. ("Lakeland" or the "Company") (NASDAQ: LAKE) have opportunity to lead the securities fraud class action lawsuit.
LOS ANGELES, April 3, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Paysafe Limited ("Paysafe" or the "Company") (NYSE: PSFE). IF YOU SUFFERED A LOSS ON YOUR PAYSAFE INVESTMENTS, CLICK HERE BEFORE APRIL 7, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
BENSALEM, Pa., April 3, 2026 /PRNewswire/ -- The Law Offices of Howard G.
BENSALEM, Pa., April 3, 2026 /PRNewswire/ -- The Law Offices of Howard G.
BENSALEM, Pa., April 3, 2026 /PRNewswire/ -- The Law Offices of Howard G.
SAN DIEGO, April 3, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Enphase Energy, Inc. (NASDAQ: ENPH) securities between April 22, 2025 and October 28, 2025. Enphase is a global energy technology company focusing on solutions for solar generation, storage, and communication.
LOS ANGELES, April 3, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against BlackRock TCP Capital Corp. ("BlackRock" or the "Company") (NASDAQ: TCPC). IF YOU SUFFERED A LOSS ON YOUR BLACKROCK INVESTMENTS, CLICK HERE BEFORE APRIL 6, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
SAN DIEGO, April 3, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States.
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is updating its investigation into uniQure N.V. (NASDAQ: QURE) a series of extraordinary rebukes by Food and Drug Administration (FDA) officials.